These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1533780)
1. Current status of chemotherapy for cancer of the cervix. Omura GA Oncology (Williston Park); 1992 Apr; 6(4):27-32; discussion 37-8, 43. PubMed ID: 1533780 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. Omura GA J Natl Cancer Inst Monogr; 1996; (21):123-6. PubMed ID: 9023841 [TBL] [Abstract][Full Text] [Related]
3. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Thigpen T; Vance RB; Khansur T Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in advanced and recurrent cervical cancer. A review. Park RC; Thigpen JT Cancer; 1993 Feb; 71(4 Suppl):1446-50. PubMed ID: 8431878 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma]. Cheng XD; Lü WG; Ye F; Chen HZ; Xie X Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856 [TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. Buda A; Fossati R; Colombo N; Fei F; Floriani I; Gueli Alletti D; Katsaros D; Landoni F; Lissoni A; Malzoni C; Sartori E; Scollo P; Torri V; Zola P; Mangioni C J Clin Oncol; 2005 Jun; 23(18):4137-45. PubMed ID: 15961761 [TBL] [Abstract][Full Text] [Related]
9. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study. Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371 [TBL] [Abstract][Full Text] [Related]
10. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix. Thigpen T; Vance R; Khansur T; Malamud F Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report. Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756 [TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the uterine cervix: current status and future directions. Thigpen T; Vance RB; Khansur T Semin Oncol; 1994 Apr; 21(2 Suppl 2):43-54; quiz 55, 58. PubMed ID: 8202720 [TBL] [Abstract][Full Text] [Related]
13. The role of paclitaxel in the management of patients with carcinoma of the cervix. Thigpen T; Vance R; Khansur T; Malamud F Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-41-S2-46. PubMed ID: 9045336 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350 [TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients]. Chauvergne J; Lhommé C; Rohart J; Héron JF; Ayme Y; Goupil A; Fargeot P; David M Bull Cancer; 1993 Dec; 80(12):1069-79. PubMed ID: 8081045 [TBL] [Abstract][Full Text] [Related]
17. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study. Vrdoljak E; Prskalo T; Omrcen T; Situm K; Boraska T; Frleta Ilić N; Janković S; Hamm W Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):824-9. PubMed ID: 15708262 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081 [TBL] [Abstract][Full Text] [Related]
19. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129 [TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]